Does ALNY pay a dividend?

The cached stock data on this page does not show a positive dividend yield for ALNY. Dividend status can change, so verify the latest company filings before relying on income assumptions.

What does ALNY stock do?

Biotechnology firm specializing in RNA interference (RNAi) therapeutics, transitioning from R&D phase to commercial profitability.

What is ALNY stock's price target?

This cached page does not contain a precise model fair value for ALNY.

The TradeMates model verdict for ALNY is HOLD with an investment score of 46/100. Treat this as a model signal to review, not a personal buy recommendation.

Is ALNY a good dividend stock?

ALNY is not presented as a dividend idea on this cached TradeMates page because no positive dividend yield is available in the cached data.

ALNY (ALNY) Stock Analysis

Q: Is ALNY stock a good investment?

The cached TradeMates AI model rates ALNY as HOLD with an investment score of 46/100. Avoid ALNY due to a significant guidance cut that breaks the growth narrative, coupled with severe technical damage and extreme valuation relative to profitable biotech peers. This is algorithmic model output, not personal investment advice.

Verdict: HOLD

Massive gap-down on revised revenue guidance signaling a growth ceiling in a niche market — the TTR franchise is no longer a 'beat and raise' story.

Investment score: 46/100

Avoid ALNY due to a significant guidance cut that breaks the growth narrative, coupled with severe technical damage and extreme valuation relative to profitable biotech peers.

Peers

REGN
950200.KQ
RVMD
NTRA
BIIB

Peer	P/E	P/B	P/S	EV/EBITDA	ROIC %	Net margin %
REGN	17.63	1.97	4.90	14.18	—	0.28
RVMD	-27.03	25.38	0.00	-30.98	—	0.00
NTRA	-165.44	21.51	15.44	-168.80	—	-0.09
BIIB	1.38	1.63	3.09	24.83	—	0.04

View the full interactive analysis